Educational Media Interventions for Cancer
(ADELANTE Trial)
Trial Summary
What is the purpose of this trial?
The study aims to develop educational media interventions to prepare Latinx Spanish-speaking radiation oncology patients for a course of breast or prostate cancer radiation therapy and to foster receptivity and informed decision-making around cancer clinical trial participation.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Audiovisual Intervention- Cancer Clinical Trials Education, Audiovisual Intervention- Radiation Therapy Education?
Is the educational media intervention for cancer safe for humans?
How does the Audiovisual Intervention for Cancer Education differ from other treatments?
The Audiovisual Intervention for Cancer Education is unique because it uses video-based educational materials to improve patients' understanding and confidence about cancer treatments, such as radiation therapy. Unlike traditional treatments that focus solely on medical procedures, this intervention aims to reduce anxiety and enhance communication by providing accessible information through engaging audiovisual content.3591011
Research Team
Lisa Kachnic, MD
Principal Investigator
Columbia University
Eligibility Criteria
This trial is for Latinx Spanish-speaking individuals with a confirmed diagnosis of non-metastatic breast or prostate cancer. They must have a Karnofsky performance status of 70 or above, indicating they are able to care for themselves. Women who can bear children need pregnancy tests as per guidelines. Participants should be planning to receive or currently undergoing curative radiation therapy and must consult using a certified interpreter.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Radiation Therapy Education
Participants receive educational material (either written brochures or audiovisual intervention) to prepare for radiation therapy
Radiation Therapy
Participants undergo radiation therapy for breast or prostate cancer
Follow-up
Participants are monitored for safety and effectiveness after treatment, including clinical trial enrollment and perceptivity
Long-term Follow-up
Participants' medical records are reviewed to ascertain subsequent cancer clinical trial enrollment
Treatment Details
Interventions
- Audiovisual Intervention- Cancer Clinical Trials Education
- Audiovisual Intervention- Radiation Therapy Education
Find a Clinic Near You
Who Is Running the Clinical Trial?
Columbia University
Lead Sponsor
Varian
Collaborator
Varian Medical Systems
Industry Sponsor
Dow R. Wilson
Varian Medical Systems
Chief Executive Officer since 2012
MBA from Dartmouth's Amos Tuck School of Business, BA from Brigham Young University
Dr. Deepak Khuntia
Varian Medical Systems
Chief Medical Officer since 2020
MD from the University of Cambridge, PhD from the University of Leicester